Bovine Respiratory Disease in Veal Calves: Benefits Associated with Its Early Detection by Lung Ultrasonography and Its Prompt Treatment with a Single Dose of a Fixed Combination of Florfenicol and Meloxicam

Lung ultrasonography can facilitate bovine respiratory disease (BRD) detection and can potentially improve treatment outcomes. In this study, ninety-six veal calves were followed weekly with clinical and lung ultrasound examinations during the production cycle. Thirty-six calves had clinical signs and abnormal lung ultrasound scans (TRT, n = 36) and were promptly treated with florfenicol and meloxicam. Healthy veal calves without clinical signs and lung lesions were enrolled in the control group (CTR, n = 48), while 12 calves were excluded by the study. The clinical (Wisconsin and California scores), ultrasound and lung lesion scores, total lung consolidation area, treatment rates (success, relapse, mortality), average daily gain (ADG), carcass quality, and gross lesions of lungs at slaughterhouse were monitored. Results showed 91.7% of treatments were performed 3-28 days after arrival. Lung lesions occurred five days before the peak of clinical scores. Following treatment, lungs healed within 5 days with high treatment success rates (97.1% success rate in 45 days and 94.9% overall success rate without relapse). Finally, TRT had similar gross lung lesion prevalence, ADG, and carcass quality to CTR. These results suggest that early detection of BRD followed by a prompt treatment can lead to several key benefits for the health and the growth performances of veal calves.